@neilstevens-phi.bsky.social
Reposted
Our collaborators at Somerset NHS FT & University Hospitals Bristol and Weston NHS FT will be presenting new data at #TheLiverMeeting #TLM25.
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
October 7, 2025 at 1:35 PM
Our collaborators at Somerset NHS FT & University Hospitals Bristol and Weston NHS FT will be presenting new data at #TheLiverMeeting #TLM25.
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
Reposted
October is #LiverCancerAwarenessMonth.
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
October 1, 2025 at 9:57 AM
October is #LiverCancerAwarenessMonth.
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
Reposted
We're heading to #BASL2025!
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
September 18, 2025 at 8:54 AM
We're heading to #BASL2025!
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
Reposted
Too many liver trials recruit from the same clinics, excluding those most affected. Our latest article looks at how broader eligibility, non-invasive tests, outreach, + case-finding can make research more representative.
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
The problem with liver trial bias, and how smart design can improve access.
Every new therapy relies on years of painstaking research, but what if that research overlooks the very people most in need? The problem: a mismatch between trials and reality Ethnic minorities, peopl...
www.linkedin.com
September 16, 2025 at 10:15 AM
Too many liver trials recruit from the same clinics, excluding those most affected. Our latest article looks at how broader eligibility, non-invasive tests, outreach, + case-finding can make research more representative.
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
Reposted
Around 80% of liver disease cases in the UK are diagnosed too late, increasing pressure on secondary care.
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
August 21, 2025 at 8:31 AM
Around 80% of liver disease cases in the UK are diagnosed too late, increasing pressure on secondary care.
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
Reposted
Addressing #SDoH is critical for equitable clinical trial access.
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
August 19, 2025 at 8:32 AM
Addressing #SDoH is critical for equitable clinical trial access.
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
Reposted
@timjobson.bsky.social joined the Surfing the MASH Tsunami podcast with Roger Green & Louise Campbell to discuss hepatoSIGHT™ and how it’s speeding better treatments to patients. A must-listen for #ClinicalTrials & #LiverDisease #LiverTwitter
podcasts.apple.com/gb/podcast/6...
podcasts.apple.com/gb/podcast/6...
6.10.3 - Expert: Tim Jobson on Using Basic Data and Analytics to Identify At-Risk Patients
Podcast Episode · Surfing the MASH Tsunami · S6, E10 Bonus · 37m
podcasts.apple.com
August 11, 2025 at 10:19 AM
@timjobson.bsky.social joined the Surfing the MASH Tsunami podcast with Roger Green & Louise Campbell to discuss hepatoSIGHT™ and how it’s speeding better treatments to patients. A must-listen for #ClinicalTrials & #LiverDisease #LiverTwitter
podcasts.apple.com/gb/podcast/6...
podcasts.apple.com/gb/podcast/6...
Reposted
#LiverDisease is often diagnosed too late. But it doesn’t have to be.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
August 8, 2025 at 10:41 AM
#LiverDisease is often diagnosed too late. But it doesn’t have to be.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
Reposted
Great to join Lyngford Park GP Surgery’s open day yesterday.
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
July 17, 2025 at 11:53 AM
Great to join Lyngford Park GP Surgery’s open day yesterday.
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
Reposted
CLDI turns "how bad, for how long?" into a precise number.
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
O06 A cumulative liver damage index (CLDI) identifies patients at risk of significant liver disease
Background Late diagnosis of liver disease is a major factor in poor outcomes, with many missed opportunities for effective interventions. Identifying at risk patients is hampered by the high prevalen...
gut.bmj.com
July 16, 2025 at 6:20 AM
CLDI turns "how bad, for how long?" into a precise number.
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
Reposted
Often, when patients with #liverdisease reach clinic, their bloods paint a familiar story. Clues that were there all along, just never seen together in time.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
July 3, 2025 at 12:03 PM
Often, when patients with #liverdisease reach clinic, their bloods paint a familiar story. Clues that were there all along, just never seen together in time.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
Reposted
Exciting News! We're at #NHSConfedExpo 2025!
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
June 9, 2025 at 9:29 AM
Exciting News! We're at #NHSConfedExpo 2025!
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
Reposted
Final day at MedTech Innovation Expo!
Great conversations at booth #G38B about tackling late liver disease diagnosis with hepatoSIGHT™.
Catch @neilstevens-phi.bsky.social at 2:30pm today on the Innovation Stage.
We're right opposite, come say hi!
#LiverDisease #MedTech #PublicHealth #NHS
Great conversations at booth #G38B about tackling late liver disease diagnosis with hepatoSIGHT™.
Catch @neilstevens-phi.bsky.social at 2:30pm today on the Innovation Stage.
We're right opposite, come say hi!
#LiverDisease #MedTech #PublicHealth #NHS
June 5, 2025 at 10:26 AM
Final day at MedTech Innovation Expo!
Great conversations at booth #G38B about tackling late liver disease diagnosis with hepatoSIGHT™.
Catch @neilstevens-phi.bsky.social at 2:30pm today on the Innovation Stage.
We're right opposite, come say hi!
#LiverDisease #MedTech #PublicHealth #NHS
Great conversations at booth #G38B about tackling late liver disease diagnosis with hepatoSIGHT™.
Catch @neilstevens-phi.bsky.social at 2:30pm today on the Innovation Stage.
We're right opposite, come say hi!
#LiverDisease #MedTech #PublicHealth #NHS
Reposted
2 days to go! Heading to Med-Tech Innovation Expo?
See how hepatoSIGHT™ is advancing liver disease detection + research.
💡 Stand #G38B / Hall 2
📍 NEC Birmingham
🗓️ 4–5 June
Book a meeting: predictivehealthintelligence.co.uk/contact/
See how hepatoSIGHT™ is advancing liver disease detection + research.
💡 Stand #G38B / Hall 2
📍 NEC Birmingham
🗓️ 4–5 June
Book a meeting: predictivehealthintelligence.co.uk/contact/
June 2, 2025 at 7:11 AM
2 days to go! Heading to Med-Tech Innovation Expo?
See how hepatoSIGHT™ is advancing liver disease detection + research.
💡 Stand #G38B / Hall 2
📍 NEC Birmingham
🗓️ 4–5 June
Book a meeting: predictivehealthintelligence.co.uk/contact/
See how hepatoSIGHT™ is advancing liver disease detection + research.
💡 Stand #G38B / Hall 2
📍 NEC Birmingham
🗓️ 4–5 June
Book a meeting: predictivehealthintelligence.co.uk/contact/
Reposted
Welcome Ben Hugill, our new Project Manager!
With experience across the NHS, local gov, and charities, most recently at Health Innovation West of England, Ben will help scale hepatoSIGHT™.
Outside work, he’s on the pitch or in the Quantocks.
Great to have you onboard!
With experience across the NHS, local gov, and charities, most recently at Health Innovation West of England, Ben will help scale hepatoSIGHT™.
Outside work, he’s on the pitch or in the Quantocks.
Great to have you onboard!
May 29, 2025 at 10:49 AM
Welcome Ben Hugill, our new Project Manager!
With experience across the NHS, local gov, and charities, most recently at Health Innovation West of England, Ben will help scale hepatoSIGHT™.
Outside work, he’s on the pitch or in the Quantocks.
Great to have you onboard!
With experience across the NHS, local gov, and charities, most recently at Health Innovation West of England, Ben will help scale hepatoSIGHT™.
Outside work, he’s on the pitch or in the Quantocks.
Great to have you onboard!
Reposted
Recruiting for liver disease trials is tough, but hepatoSIGHT™ can help.
Use real-world data to choose the right sites, reduce screen failures, and enrol faster, even in complex studies.
predictivehealthintelligence.co.uk/professional...
#ClinicalTrials #LiverResearch #LiverDisease
Use real-world data to choose the right sites, reduce screen failures, and enrol faster, even in complex studies.
predictivehealthintelligence.co.uk/professional...
#ClinicalTrials #LiverResearch #LiverDisease
May 28, 2025 at 8:24 AM
Recruiting for liver disease trials is tough, but hepatoSIGHT™ can help.
Use real-world data to choose the right sites, reduce screen failures, and enrol faster, even in complex studies.
predictivehealthintelligence.co.uk/professional...
#ClinicalTrials #LiverResearch #LiverDisease
Use real-world data to choose the right sites, reduce screen failures, and enrol faster, even in complex studies.
predictivehealthintelligence.co.uk/professional...
#ClinicalTrials #LiverResearch #LiverDisease
Reposted
We’re thrilled to announce hepatoSIGHT™ is now live across the South West, reaching 6M people to tackle liver disease!
Join us at the launch: 14 May, Exeter.
Details & RSVP 👉 mark.wall@predictivehealthintelligence.co.uk
#EASL #LiverDisease #PublicHealth
Join us at the launch: 14 May, Exeter.
Details & RSVP 👉 mark.wall@predictivehealthintelligence.co.uk
#EASL #LiverDisease #PublicHealth
May 7, 2025 at 9:42 AM
We’re thrilled to announce hepatoSIGHT™ is now live across the South West, reaching 6M people to tackle liver disease!
Join us at the launch: 14 May, Exeter.
Details & RSVP 👉 mark.wall@predictivehealthintelligence.co.uk
#EASL #LiverDisease #PublicHealth
Join us at the launch: 14 May, Exeter.
Details & RSVP 👉 mark.wall@predictivehealthintelligence.co.uk
#EASL #LiverDisease #PublicHealth
Reposted
We’re exhibiting at Med-Tech Innovation Expo 2025!
💡 Stand #G38B / Hall 2
📍 NEC, Birmingham, UK
🗓️ 4–5 June 2025
Meet us there and explore how hepatoSIGHT™ is transforming early detection and risk stratification in liver disease.
#MedTechExpo2025 #HealthInnovation #LiverDisease
💡 Stand #G38B / Hall 2
📍 NEC, Birmingham, UK
🗓️ 4–5 June 2025
Meet us there and explore how hepatoSIGHT™ is transforming early detection and risk stratification in liver disease.
#MedTechExpo2025 #HealthInnovation #LiverDisease
May 6, 2025 at 1:23 PM
We’re exhibiting at Med-Tech Innovation Expo 2025!
💡 Stand #G38B / Hall 2
📍 NEC, Birmingham, UK
🗓️ 4–5 June 2025
Meet us there and explore how hepatoSIGHT™ is transforming early detection and risk stratification in liver disease.
#MedTechExpo2025 #HealthInnovation #LiverDisease
💡 Stand #G38B / Hall 2
📍 NEC, Birmingham, UK
🗓️ 4–5 June 2025
Meet us there and explore how hepatoSIGHT™ is transforming early detection and risk stratification in liver disease.
#MedTechExpo2025 #HealthInnovation #LiverDisease
Reposted
hepatosight™ is rolling out across SW England, serving 6 million people, enabling early detection of liver disease, and facilitating faster clinical trial recruitment for urgently needed new treatments.
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
May 1, 2025 at 10:43 AM
hepatosight™ is rolling out across SW England, serving 6 million people, enabling early detection of liver disease, and facilitating faster clinical trial recruitment for urgently needed new treatments.
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
Meet our team at EASL next week to discuss.
#EASL2025 #LiverDisease #ClinicalResearch
Reposted
BREAKING NEWS: hepatoSIGHT™ now available to 6 million people across South West England!
#Liverdisease represents a #publichealth crisis, with premature deaths increasing by 42% from 2001 to 2023.
💬 1/5
#Liverdisease represents a #publichealth crisis, with premature deaths increasing by 42% from 2001 to 2023.
💬 1/5
April 29, 2025 at 11:07 AM
BREAKING NEWS: hepatoSIGHT™ now available to 6 million people across South West England!
#Liverdisease represents a #publichealth crisis, with premature deaths increasing by 42% from 2001 to 2023.
💬 1/5
#Liverdisease represents a #publichealth crisis, with premature deaths increasing by 42% from 2001 to 2023.
💬 1/5
Reposted
Liver disease burden in the UK:
👉 1 in 10 have signs of possible liver damage (1).
👉 Number of deaths are rising in England (2).
👉 Premature mortality rate is increasing in England (2).
👉 Hospital admissions are rising in England (2).
👉 Liver cancer incidence + mortality are increasing (3,4).
💬 1/2
👉 1 in 10 have signs of possible liver damage (1).
👉 Number of deaths are rising in England (2).
👉 Premature mortality rate is increasing in England (2).
👉 Hospital admissions are rising in England (2).
👉 Liver cancer incidence + mortality are increasing (3,4).
💬 1/2
April 22, 2025 at 11:53 AM
Liver disease burden in the UK:
👉 1 in 10 have signs of possible liver damage (1).
👉 Number of deaths are rising in England (2).
👉 Premature mortality rate is increasing in England (2).
👉 Hospital admissions are rising in England (2).
👉 Liver cancer incidence + mortality are increasing (3,4).
💬 1/2
👉 1 in 10 have signs of possible liver damage (1).
👉 Number of deaths are rising in England (2).
👉 Premature mortality rate is increasing in England (2).
👉 Hospital admissions are rising in England (2).
👉 Liver cancer incidence + mortality are increasing (3,4).
💬 1/2
Reposted
Today is World Liver Day!
This year’s theme, “Food is Medicine,” highlights how a healthy diet can prevent and manage liver diseases like MASLD.
Let’s raise awareness to improve access to nutritious foods, supporting better liver health for all!
#WorldLiverDay #FoodIsMedicine
This year’s theme, “Food is Medicine,” highlights how a healthy diet can prevent and manage liver diseases like MASLD.
Let’s raise awareness to improve access to nutritious foods, supporting better liver health for all!
#WorldLiverDay #FoodIsMedicine
April 18, 2025 at 11:02 AM
Today is World Liver Day!
This year’s theme, “Food is Medicine,” highlights how a healthy diet can prevent and manage liver diseases like MASLD.
Let’s raise awareness to improve access to nutritious foods, supporting better liver health for all!
#WorldLiverDay #FoodIsMedicine
This year’s theme, “Food is Medicine,” highlights how a healthy diet can prevent and manage liver diseases like MASLD.
Let’s raise awareness to improve access to nutritious foods, supporting better liver health for all!
#WorldLiverDay #FoodIsMedicine
Reposted
Why is #casefinding for chronic #liverdisease beneficial for #publichealth?
Liver disease is increasing + a leading cause of early death in the UK. Early detection through case-finding can ease the burden by limiting disease progression.
🔗 predictivehealthintelligence.co.uk
Liver disease is increasing + a leading cause of early death in the UK. Early detection through case-finding can ease the burden by limiting disease progression.
🔗 predictivehealthintelligence.co.uk
April 15, 2025 at 10:22 AM
Why is #casefinding for chronic #liverdisease beneficial for #publichealth?
Liver disease is increasing + a leading cause of early death in the UK. Early detection through case-finding can ease the burden by limiting disease progression.
🔗 predictivehealthintelligence.co.uk
Liver disease is increasing + a leading cause of early death in the UK. Early detection through case-finding can ease the burden by limiting disease progression.
🔗 predictivehealthintelligence.co.uk
Reposted
The (near) future of liver disease care – part two: diagnostics.
With disease-modifying therapies on the horizon, accurately identifying and monitoring patients with MASLD/MASH is now a clinical and system-level priority.
#LiverDisease #MASLD #Diagnostics
With disease-modifying therapies on the horizon, accurately identifying and monitoring patients with MASLD/MASH is now a clinical and system-level priority.
#LiverDisease #MASLD #Diagnostics
April 10, 2025 at 1:25 PM
The (near) future of liver disease care – part two: diagnostics.
With disease-modifying therapies on the horizon, accurately identifying and monitoring patients with MASLD/MASH is now a clinical and system-level priority.
#LiverDisease #MASLD #Diagnostics
With disease-modifying therapies on the horizon, accurately identifying and monitoring patients with MASLD/MASH is now a clinical and system-level priority.
#LiverDisease #MASLD #Diagnostics